Kaushik J. Dave, CEO and Interim CFO at Actinium Pharmaceuticals, Inc. (ATNM), bought 10,000 shares at $2.02 ($20K) on 2016-04-14, disclosed to the SEC on 2016-04-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 2,000 | $4K | 19.9% |
| 2 | $2.02 | 8,000 | $16K | 80.1% |
| Total | $2.02 avg | 10,000 | $20K | 100% |
| Filing → |